1 Mortality in trials with a low or high risk of bias |
78 |
296707 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.98, 1.05] |
1.1 Trials with low risk of bias |
56 |
244056 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [1.01, 1.07] |
1.2 Trials with high risk of bias |
22 |
52651 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.85, 0.98] |
2 Mortality in 76 trials with a low or high risk of bias with assigned fatalities to all of the dropouts |
76 |
263805 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.99, 1.03] |
2.1 Trials with low risk of bias |
55 |
240738 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.99, 1.04] |
2.2 Trials with high risk of bias |
21 |
23067 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.86, 0.99] |
3 Mortality in primary and secondary prevention trials with a low or high risk of bias |
78 |
296707 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.98, 1.05] |
3.1 Primary prevention trials with a low risk of bias |
19 |
177868 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.97, 1.08] |
3.2 Secondary prevention trials with a low risk of bias |
37 |
66188 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.99, 1.07] |
3.3 Primary prevention trials with a high risk of bias |
7 |
38032 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.84, 1.03] |
3.4 Secondary prevention trials with a high risk of bias |
15 |
14619 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.81, 0.99] |
4 Mortality after excluding trials administrating extra supplements in the antioxidant group |
60 |
249526 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.99, 1.06] |
4.1 Trials with low risk of bias |
43 |
227700 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [1.01, 1.07] |
4.2 Trials with high risk of bias |
17 |
21826 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.82, 1.00] |
5 Mortality after excluding trials with extra supplements for both intervention groups |
63 |
283619 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.99, 1.05] |
5.1 Trials with low risk of bias |
48 |
233249 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [1.00, 1.07] |
5.2 Trials with high risk of bias |
15 |
50370 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.86, 1.00] |
6 Mortality after excluding factorial trials with potential confounding |
52 |
60544 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.94, 1.08] |
6.1 Trials with low risk of bias |
38 |
52955 |
Risk Ratio (M‐H, Random, 95% CI) |
1.10 [1.05, 1.15] |
6.2 Trials with high risk of bias |
14 |
7589 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.73, 0.97] |
7 Mortality after excluding factorial trials with potential confounding and trials with extra supplements |
36 |
53542 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.92, 1.11] |
7.1 Trials with low risk of bias |
27 |
46783 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [1.06, 1.18] |
7.2 Trials with a high risk of bias |
9 |
6759 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.73, 0.98] |
8 Mortality in beta‐carotene trials with a low or high risk of bias |
31 |
195503 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.98, 1.07] |
8.1 Trials with a low risk of bias |
26 |
173006 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [1.01, 1.09] |
8.2 Trials with a high risk of bias |
5 |
22497 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.62, 1.07] |
9 Mortality in vitamin A trials with a low or high risk of bias |
18 |
61190 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.96, 1.13] |
9.1 Trials with a low risk of bias |
12 |
41144 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.97, 1.18] |
9.2 Trials with a high risk of bias |
6 |
20046 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.85, 1.07] |
10 Mortality in vitamin C trials with a low or high risk of bias |
41 |
90191 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.97, 1.05] |
10.1 Trials with a low risk of bias |
29 |
65942 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.98, 1.07] |
10.2 Trials with a high risk of bias |
12 |
24249 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.84, 1.04] |
11 Mortality in vitamin E trials with a low or high risk of bias |
64 |
211957 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.99, 1.04] |
11.1 Trials with a low risk of bias |
46 |
171244 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [1.00, 1.05] |
11.2 Trials with a high risk of bias |
18 |
40713 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.85, 0.99] |
12 Mortality in selenium trials with a low or high risk of bias |
24 |
86150 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.91, 1.01] |
12.1 Trials with a low risk of bias |
17 |
62740 |
Risk Ratio (M‐H, Random, 95% CI) |
0.97 [0.91, 1.03] |
12.2 Trials with a high risk of bias |
7 |
23410 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.81, 1.01] |